Follow
Jingzhen Yang
Jingzhen Yang
Verified email at nationwidechildrens.org
Title
Cited by
Cited by
Year
LD Score regression distinguishes confounding from polygenicity in genome-wide association studies
BK Bulik-Sullivan, PR Loh, HK Finucane, S Ripke, J Yang, ...
Nature genetics 47 (3), 291-295, 2015
42362015
Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma
SA Rosenberg, BS Packard, PM Aebersold, D Solomon, SL Topalian, ...
New England Journal of Medicine 319 (25), 1676-1680, 1988
30781988
Acute effects and recovery time following concussion in collegiate football players: the NCAA Concussion Study
M McCrea, KM Guskiewicz, SW Marshall, W Barr, C Randolph, RC Cantu, ...
Jama 290 (19), 2556-2563, 2003
18662003
New genetic loci link adipose and insulin biology to body fat distribution
D Shungin, TW Winkler, DC Croteau-Chonka, T Ferreira, AE Locke, ...
Nature 518 (7538), 187-196, 2015
15962015
Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution
IM Heid, AU Jackson, JC Randall, TW Winkler, L Qi, V Steinthorsdottir, ...
Nature genetics 42 (11), 949-960, 2010
10962010
Genetic variance estimation with imputed variants finds negligible missing heritability for human height and body mass index
J Yang, A Bakshi, Z Zhu, G Hemani, AAE Vinkhuyzen, SH Lee, ...
Nature genetics 47 (10), 1114-1120, 2015
8422015
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
7142021
Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial
L Paz-Ares, EH Tan, K O’Byrne, L Zhang, V Hirsh, M Boyer, JCH Yang, ...
Annals of Oncology 28 (2), 270-277, 2017
5582017
Osimertinib As First-Line Treatment of EGFR Mutation–Positive Advanced Non–Small-Cell Lung Cancer
SS Ramalingam, JCH Yang, CK Lee, T Kurata, DW Kim, T John, ...
Journal of Clinical Oncology 36 (9), 841-849, 2018
5262018
Prevalence of and risk factors associated with symptoms of depression in competitive collegiate student athletes
J Yang, C Peek-Asa, JD Corlette, G Cheng, DT Foster, J Albright
Clinical journal of sport medicine 17 (6), 481-487, 2007
5052007
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally …
D Miles, J Gligorov, F André, D Cameron, A Schneeweiss, C Barrios, B Xu, ...
Annals of Oncology 32 (8), 994-1004, 2021
4352021
Amivantamab in EGFR exon 20 insertion–mutated non–small-cell lung cancer progressing on platinum chemotherapy: initial results from the CHRYSALIS phase I study
K Park, EB Haura, NB Leighl, P Mitchell, CA Shu, N Girard, S Viteri, ...
Journal of Clinical Oncology 39 (30), 3391, 2021
4262021
Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study
A Bhangu, AO Ademuyiwa, ML Aguilera, P Alexander, SW Al-Saqqa, ...
The Lancet Infectious Diseases 18 (5), 516-525, 2018
4092018
The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo.
JJ Mule, S Shu, SA Rosenberg
Journal of immunology (Baltimore, Md.: 1950) 135 (1), 646-652, 1985
4041985
The power of genetic diversity in genome-wide association studies of lipids
SE Graham, SL Clarke, KHH Wu, S Kanoni, GJM Zajac, S Ramdas, ...
Nature 600 (7890), 675-679, 2021
3952021
Incidence and risk factors for concussion in high school athletes, North Carolina, 1996–1999
MR Schulz, SW Marshall, FO Mueller, J Yang, NL Weaver, WD Kalsbeek, ...
American journal of epidemiology 160 (10), 937-944, 2004
3762004
Epidemiology of overuse and acute injuries among competitive collegiate athletes
J Yang, AS Tibbetts, T Covassin, G Cheng, S Nayar, E Heiden
Journal of athletic training 47 (2), 198-204, 2012
3702012
TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer
GR Oxnard, JCH Yang, H Yu, SW Kim, H Saka, L Horn, K Goto, Y Ohe, ...
Annals of Oncology 31 (4), 507-516, 2020
3352020
Quantifying and modelling fabric anisotropy of granular soils
ZX Yang, XS Li, J Yang
Géotechnique 58 (4), 237-248, 2008
3282008
Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189
D Rodríguez-Abreu, SF Powell, MJ Hochmair, S Gadgeel, E Esteban, ...
Annals of Oncology 32 (7), 881-895, 2021
3152021
The system can't perform the operation now. Try again later.
Articles 1–20